Diagnosis of PMF requires demonstration of myeloproliferative mutational markers such as JAK2 or CALR mutation and evaluation of potential causes of secondary myelofibrosis, including infection, autoimmune diseases, chronic inflammatory disorders, malignancies, and toxic agents [2]. This evidence concerns the gene JAK2 and infection.